Showing results (191-200 of 226) with videos related to

Sort By:
Pageof 23
International Journal of Radiation Oncology, Biology, Physics|September 11, 2017
Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone ExposureInge M Krul, Annemieke W J Opstal-van Winden, Berthe M P Aleman, et al.
Leukemia|May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trialGerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
The Lancet Regional Health. Europe|May 2, 2022
Efficacy of the eHealth application Oncokompas, facilitating incurably ill cancer patients to self-manage their palliative care needs: A randomized controlled trialAnouk S Schuit, Karen Holtmaat, Birgit I Lissenberg-Witte, et al.
Leukemia|October 16, 2023
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphomaMichael Fuchs, Anne Sophie Jacob, Helen Kaul, et al.
Cell Reports. Medicine|September 17, 2025
Circulating extracellular vesicle isomiR signatures predict therapy response in patients with multiple myelomaCristina Gómez-Martín, Esther E E Drees, Monique A J van Eijndhoven, et al.
Cancer Medicine|August 5, 2025
Influence of Survivorship Care on Health-Related Quality of Life, Knowledge of Late Effects, and Distress Levels Among Long-Term Hodgkin Lymphoma SurvivorsEline M J Lammers, Annelies Nijdam, Michael Schaapveld, et al.
The New England Journal of Medicine|December 25, 2015
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's LymphomaMichael Schaapveld, Berthe M P Aleman, Anna M van Eggermond, et al.
Cancers|February 15, 2022
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL StudyJosée M Zijlstra, George Follows, Rene-Olivier Casasnovas, et al.
Journal of Cancer Survivorship : Research and Practice|July 15, 2026
Knowledge gaps among adult Hodgkin lymphoma survivors: implications for risk‑based careSophia K Smith, Lonneke V van de Poll-Franse, Eline M J Lammers, et al.
The Lancet. Haematology|May 28, 2021
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trialStefanie Kreissl, Helen Goergen, Ina Buehnen, et al.
Pageof 23